ConductScience.org, home

Paper39268652

Fc-FcγR interactions during infections: From neutralizing antibodies to antibody-dependent enhancement.

Edgar JE and 1 other. Immunol Rev, 2024. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Fc-FcγR interactions during infections: From neutralizing antibodies to antibody-dependent enhancement. Papers, record 39268652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39268652

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Fc-FcγR interactions during infections: From neutralizing antibodies to antibody-dependent enhancement.
PubMed
Journal
Immunol Rev
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
3.02, provisional
iCite
Revised in PubMed
2026-09-23
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Edgar JEJulia E
2Bournazos SStylianoshttps://orcid.org/0000-0001-5466-5620

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, NeutralizingMajor topic
Antibody-Dependent EnhancementMajor topic
Immunoglobulin Fc FragmentsMajor topic
Receptors, IgGMajor topic
Animals
Humans
Antibodies, Monoclonal
Antibodies, Viral
Virus Diseases

Source PubMed

Download CSV of topics

Grants8

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U19AI111825National Institute of Allergy and Infectious DiseasesU19AI111825PubMed and NIHNIH RePORTER
R01CA244327NCI NIH HHSUnited StatesR01CA244327PubMed and NIHNIH RePORTER
R01 AI145870NIAID NIH HHSUnited StatesR01AI145870PubMed and NIHNIH RePORTER
R01 AI137276NIAID NIH HHSUnited StatesR01AI137276PubMed and NIHNIH RePORTER
R01AI145870National Institute of Allergy and Infectious DiseasesR01AI145870PubMed and NIHNIH RePORTER
U19 AI111825NIAID NIH HHSUnited StatesU19AI111825PubMed and NIHNIH RePORTER
R01 CA244327NCI NIH HHSUnited StatesR01CA244327PubMed and NIHNIH RePORTER
R01AI137276National Institute of Allergy and Infectious DiseasesR01AI137276PubMed and NIHNIH RePORTER

Download CSV of grants

References289

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133972256
Tolerability, Safety, Pharmacokinetics, and Immunogenicity of a Novel SARS-CoV-2 Neutralizing Antibody, Etesevimab, in Chinese Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, First-in-Human Phase 1 Study.
Antimicrob Agents Chemother2021https://conductscience.org/library/papers/33972256PubMed
226497511Mouse and human FcR effector functions.Immunol Rev2015https://conductscience.org/library/papers/26497511PubMed
328679958Fc functional antibodies in humans with severe H7N9 and seasonal influenza.JCI Insight2017https://conductscience.org/library/papers/28679958PubMed
417240489Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates.Vaccine2007https://conductscience.org/library/papers/17240489PubMed
532209433Antigen-Induced Allosteric Changes in a Human IgG1 Fc Increase Low-Affinity Fcγ Receptor Binding.Structure2020https://conductscience.org/library/papers/32209433PubMed
627354365Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge.J Infect Dis2016https://conductscience.org/library/papers/27354365PubMed
717704420FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.J Clin Oncol2007https://conductscience.org/library/papers/17704420PubMed
832540901Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail.Science2020https://conductscience.org/library/papers/32540901PubMed
919841167Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients.J Immunol2009https://conductscience.org/library/papers/19841167PubMed
1022531445Development and validation of an antibody-dependent cell-mediated cytotoxicity-reporter gene assay.MAbs2012https://conductscience.org/library/papers/22531445PubMed
1115466916The coordination of signaling during Fc receptor-mediated phagocytosis.J Leukoc Biol2004https://conductscience.org/library/papers/15466916PubMed
1210403650SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis.Immunity1999https://conductscience.org/library/papers/10403650PubMed
1325215485Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity.Cell2014https://conductscience.org/library/papers/25215485PubMed
141564451Infection enhancement of influenza A NWS virus in primary murine macrophages by anti-hemagglutinin monoclonal antibody.J Med Virol1992https://conductscience.org/library/papers/1564451PubMed
1515043007Virus entry: molecular mechanisms and biomedical applications.Nat Rev Microbiol2004https://conductscience.org/library/papers/15043007PubMed
1622908282Autonomous phagosomal degradation and antigen presentation in dendritic cells.Proc Natl Acad Sci U S A2012https://conductscience.org/library/papers/22908282PubMed
1714700166Clinical presentations of dengue hemorrhagic fever in infants compared to children.J Med Assoc Thai2003https://conductscience.org/library/papers/14700166PubMed
1832525844Early safety indicators of COVID-19 convalescent plasma in 5000 patients.J Clin Invest2020https://conductscience.org/library/papers/32525844PubMed
1928812955IgG cooperativity - Is there allostery? Implications for antibody functions and therapeutic antibody development.MAbs2017https://conductscience.org/library/papers/28812955PubMed
2035690075Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies.Lancet Infect Dis2022https://conductscience.org/library/papers/35690075PubMed

See all 289 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
42750812Epitope-driven polyfunctional divergence of SARS-CoV-2 RBD antibodies.iScience2026https://conductscience.org/library/papers/42750812PubMed
42750060Mechanisms of antibody-dependent enhancement and its research progress in animal coronaviruses.Vet Res2026https://conductscience.org/library/papers/42750060PubMed
42639460Immunobridging Analysis of Pemivibart for the Treatment of COVID-19: A Therapeutic Gap for the Immune-Compromised Population Remains.Open Forum Infect Dis2026https://conductscience.org/library/papers/42639460PubMed
42439638Distinct Innate and Adaptive Immune Modules Differentially Associate with HIV Reservoir Size and Decay During Early Antiretroviral Therapy.Cells2026https://conductscience.org/library/papers/42439638PubMed
42337147Clinical Manifestations and Immunological Impacts in Co-Infections and Sequential Infections of SARS-CoV-2 and Arboviruses.Curr Microbiol2026https://conductscience.org/library/papers/42337147PubMed
42327721Polyfunctional antibody signature defines protection in Andes hantavirus survival.Front Immunol2026https://conductscience.org/library/papers/42327721PubMed
42199422Fc effector functions in RNA viral infections: mechanisms of antiviral immunity and implications for vaccine design.Front Immunol2026https://conductscience.org/library/papers/42199422PubMed
42148106Determinants of success and failure of antibody-based strategies against respiratory viruses: insights from RSV and SARS-CoV-2.Front Immunol2026https://conductscience.org/library/papers/42148106PubMed
41709436Antibody-Antibiotic Conjugates: Mechanisms, Clinical Progress, and Next-Generation Strategies Against Multidrug-Resistant Bacterial Infections.Microbiologyopen2026https://conductscience.org/library/papers/41709436PubMed
41149075The Yin and Yang of Antibodies in Viral Infectious Diseases.Diseases2025https://conductscience.org/library/papers/41149075PubMed
41136184Characteristics of an antibody profile associated with protection against hepatitis C virus reinfection in a high-risk cohort.Gut2026https://conductscience.org/library/papers/41136184PubMed
41012704
Antibody-Dependent Enhancement of Porcine Reproductive and Respiratory Syndrome Virus Infection Antagonizes the Secretion of Type I Interferons in Porcine Alveolar Macrophages by Interfering with the Retinoic Acid-Inducible Gene I/Melanoma Differentiation-Associated Gene 5 Pathway via Fc Gamma Receptor I.
Viruses2025https://conductscience.org/library/papers/41012704PubMed
40989107Reprogramming the tumor microenvironment: synergistic mechanisms of antibody-drug conjugates and immune checkpoint inhibitors.Antib Ther2025https://conductscience.org/library/papers/40989107PubMed
40591599FcγRIIIa is a noncanonical costimulatory molecule for CD8 T cells.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40591599PubMed
40489867The hot spots and trends of Fc gamma receptor: A bibliometric analysis from 2004 to 2024.Medicine (Baltimore)2025https://conductscience.org/library/papers/40489867PubMed
40249965Maternal Antibodies to Neurovirulent Pathogens in Fetal Tissues.Annu Rev Virol2025https://conductscience.org/library/papers/40249965PubMed
40105005Autovaccination revisited: potential to boost antiviral immunity and facilitate HIV-1 cure/remission in children.Curr Opin HIV AIDS2025https://conductscience.org/library/papers/40105005PubMed
39268652Fc-FcγR interactions during infections: From neutralizing antibodies to antibody-dependent enhancement.Immunol Rev2024https://conductscience.org/library/papers/39268652PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39268652

GET https://conductscience.org/api/papers/v1/39268652/references?page=2